In a 62‑year‑old woman with mild obstructive sleep apnea well controlled with continuous positive airway pressure (CPAP) who now has unilateral diaphragm paralysis on sniff fluoroscopy and heart‑failure with preserved ejection fraction (EF 63 %) diagnosed by cardiac catheterization, under what circumstances should she be switched from CPAP to bilevel positive airway pressure (BiPAP) and subsequently from BiPAP to adaptive servo‑ventilation (ASV)?

When to Switch from CPAP to BiPAP and Then to ASV

In this patient with HFpEF (EF 63%) and unilateral diaphragm paralysis, switch from CPAP to BiPAP with backup rate if she develops central sleep apnea (treatment-emergent CSA) documented on sleep study or PAP download data, or if she develops symptomatic hypoventilation with hypercapnia due to her diaphragm paralysis. Subsequently, escalate from BiPAP to ASV if central apneas persist despite BiPAP with backup rate and she remains symptomatic with poor quality of life.

Clinical Decision Algorithm

Step 1: Monitor for Indications to Switch from CPAP to BiPAP

The key trigger points are:

• Development of treatment-emergent central sleep apnea (TE-CSA): Review PAP download data showing emergence of central apneas (typically central apnea index >5/hour or central events comprising >50% of total respiratory events) 1

• Symptomatic hypoventilation: The unilateral diaphragm paralysis creates ventilatory pump limitation that may manifest as:

  • Worsening orthopnea or dyspnea when supine
  • Daytime hypercapnia (PaCO2 >45 mmHg)
  • Nocturnal hypoventilation documented on sleep study
  • Morning headaches, excessive daytime sleepiness beyond what OSA alone would cause

• Persistent symptoms despite adequate CPAP: If she develops new or worsening dyspnea, fatigue, or quality of life decline despite documented CPAP adherence and adequate pressure

Critical caveat: The 2025 AASM guidelines explicitly recommend against BiPAP without backup rate for CSA, as this mode can worsen central apneas by triggering hyperventilation and hypocapnia 1. If switching to BiPAP, it must include a backup rate to ensure minimum ventilation and prevent central apnea development.

Step 2: Confirm Need for BiPAP with Objective Testing

Before switching, obtain:

• PAP device download data: Modern CPAP machines detect central vs obstructive events. Look for rising central apnea index over time
• Repeat sleep study on CPAP: If download data suggests TE-CSA or symptoms worsen, perform attended polysomnography on current CPAP settings to quantify central events
• Daytime arterial blood gas: Check for hypercapnia related to diaphragm dysfunction
• Positional spirometry: Document restrictive defect worsening in supine position (as seen with diaphragm paralysis)

Step 3: When to Escalate from BiPAP to ASV

Switch to ASV if:

• Persistent central apneas on BiPAP with backup rate: After adequate trial (typically 4-8 weeks) with optimized settings, if central apnea index remains >5/hour or patient remains symptomatic 1

• Poor quality of life or persistent symptoms: Continued orthopnea, excessive sleepiness, fatigue, or reduced functional capacity despite BiPAP adherence

• Patient-reported outcomes drive the decision: The 2025 AASM guidelines emphasize that ASV decisions should be based on "expectations of symptomatic or quality-of-life improvement" rather than solely eliminating respiratory events 1

Critical Safety Considerations for ASV in HFpEF

This patient has HFpEF (EF 63%), NOT HFrEF, which is a crucial distinction:

• The SERVE-HF trial that showed increased mortality involved patients with HFrEF (EF ≤45%), not HFpEF 1, 2

• ASV is conditionally recommended for CSA in heart failure by the 2025 AASM guidelines, with the caveat that in HFrEF it should be "limited to centers with experience, along with close monitoring and follow-up" 1

• The 2025 European Respiratory Society statement clarifies that ASV can be used in patients with LVEF 30-45% in expert centers, and is not contraindicated in HFpEF 2

• With EF 63%, this patient is in the HFpEF range where ASV safety concerns from SERVE-HF do not apply 2

• Recent meta-analyses found no class effect of ASV on mortality in heart failure patients, and ASV consistently improves quality of life and disease severity 1

Practical Implementation

For BiPAP Initiation:

• Requires formal PAP titration study to set appropriate inspiratory/expiratory pressures and backup rate
• Backup rate typically set 2-4 breaths below patient's spontaneous rate
• Monitor with device downloads at 2-4 weeks, then monthly initially

For ASV Initiation:

• Requires attended titration study with experienced sleep technologist
• Engage in shared decision-making with patient about expectations for symptom improvement 1
• Close follow-up with device downloads and clinical assessment
• Coordinate with cardiology given HFpEF diagnosis

The Diaphragm Paralysis Factor

The unilateral diaphragm paralysis adds complexity:

• Creates baseline restrictive ventilatory impairment and positional dyspnea
• May cause or worsen hypoventilation, especially supine
• BiPAP with backup rate provides ventilatory support that CPAP cannot
• The backup rate ensures minimum minute ventilation despite reduced diaphragm function
• This mechanical consideration may necessitate BiPAP even without documented central apneas, purely for ventilatory support

Bottom line: The diaphragm paralysis itself may be sufficient indication for BiPAP with backup rate if she develops symptomatic hypoventilation, independent of whether central apneas emerge.